# AstraZeneca Pharmaceuticals LP – FDA Inspection, Oct 25, 2024

Source: https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/da96b405-5d6f-462e-8164-cc589345ae2e
Source feed: FDA_Inspections

> FDA inspection 1254239 of AstraZeneca Pharmaceuticals LP, October 25, 2024. 15 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254239
- Company Name: AstraZeneca Pharmaceuticals LP
- Inspection Date: 2024-10-25
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Baltimore District Office
- Citation Count: 0

## Related Documents

- FDA Inspection 1299436 - 2026-01-14
- [FDA Inspection 1238346 - 2024-05-31](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f4d9b1b5-b5fa-492a-8363-3e39782013b0)
- FDA Inspection 1230136 - 2024-01-22
- FDA Inspection 1211604 - 2023-07-18
- FDA Inspection 1157291 - 2021-09-30

## Related Officers

- [Company Rep](https://www.keypedia.com/people/brittany-l-carpenter/600db4d0-0b6b-435f-b511-2ca10f292d5d)

Company: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/f2e34b74-3ef4-4f39-8f6f-41eceb3bb779

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa